基于肠道微生物组学探究苍术花椒药 对改善小鼠溃疡性结肠炎作用
Exploring the Effect of Atractylodis Rhizoma-Zanthoxyli Pericarpium Herb Pairs on Improving Ulcerative Colitis in Mice Based on Gut Microbiomics
DOI: 10.12677/hjbm.2026.164074, PDF,    科研立项经费支持
作者: 李子巍*:东北林业大学食品与健康学院,黑龙江 哈尔滨;张 琳#:东北林业大学食品与健康学院,黑龙江 哈尔滨;东北林业大学森林植物生态学教育部重点实验室,黑龙江 哈尔滨;黑龙江省林源活性物质生态利用重点实验室,黑龙江 哈尔滨
关键词: 溃疡性结肠炎苍术花椒肠道菌群Ulcerative Colitis Atractylodis Rhizoma Zanthoxyli Pericarpium Intestinal Microbiota
摘要: 目的:探讨苍术–花椒药对对葡聚糖硫酸钠(DSS)诱导的结肠炎小鼠的治疗作用及机制,明确其对临床症状、肠道炎症、菌群稳态的调控,为临床应用提供理论依据。方法:采用3% (w/v) DSS诱导小鼠溃疡性结肠炎模型。将小鼠随机分为空白对照组、模型组、阳性对照组、苍术组、花椒组、苍术–花椒药对高中低剂量组。给药结束后,以腹泻指标与肠道菌群特征为依据,评价苍术–花椒药对对溃疡性结肠炎的治疗作用。结果:DSS成功诱导UC小鼠模型,表现为结肠缩短、促炎因子水平升高及肠道菌群多样性下降、厚壁菌门/拟杆菌门比值失衡、关键菌科(MuribaculaceaeLachnospiraceae)丰度紊乱。苍术–花椒高剂量组可显著改善UC小鼠结肠长度与炎症因子水平,效果与柳氮磺吡啶(SASP)相当且优于单药组;同时可有效逆转肠道菌群多样性与结构失衡,回调关键菌科丰度,呈现显著的配伍协同效应。结论:苍术–花椒药对可有效治疗DSS诱导的UC小鼠,其作用机制与调控肠道菌群多样性、改善菌群组成失衡密切相关,为UC的中医药临床治疗提供了实验依据。
Abstract: Objective: This study aimed to investigate the therapeutic effect and underlying mechanism of Atractylodis Rhizoma-Zanthoxyli Pericarpium herb pair on dextran sulfate sodium (DSS)-induced colitis in mice, clarify its regulatory effects on clinical symptoms, intestinal inflammation and gut microbiota homeostasis, and provide a theoretical basis for its clinical application. Methods: A mouse model of ulcerative colitis (UC) was established by administration of 3% (w/v) DSS. Mice were randomly divided into blank control group, model group, positive control group, Atractylodis Rhizoma group, Zanthoxyli Pericarpium group, and high, medium and low dose groups of Atractylodis Rhizoma-Zanthoxyli Pericarpium herb pair. After the treatment period, the therapeutic effect of the herb pair on UC was evaluated according to diarrhea-related indices and gut microbiota characteristics. Results: DSS successfully induced UC in mice, characterized by shortened colon, elevated pro-inflammatory cytokine levels, decreased gut microbiota diversity, an imbalanced ratio of Firmicutes to Bacteroidetes, and disturbed abundances of key bacterial families (Muribaculaceae, Lachnospiraceae). The high-dose Atractylodis Rhizoma-Zanthoxyli Pericarpium herb pair group significantly ameliorated colon length and inflammatory cytokine levels in UC mice, with an efficacy comparable to that of sulfasalazine (SASP) and superior to the single-herb groups. Meanwhile, it effectively reversed the imbalance in gut microbiota diversity and structure, restored the abundances of key bacterial families, and exhibited a significant synergistic effect of the herb combination. Conclusion: The Atractylodis Rhizoma-Zanthoxyli Pericarpium herb pair effectively alleviated DSS-induced UC in mice. Its mechanism is closely associated with the regulation of gut microbiota diversity and the improvement of microbial compositional imbalance, providing experimental evidence for the clinical application of traditional Chinese medicine in the treatment of UC.
文章引用:李子巍, 张琳. 基于肠道微生物组学探究苍术花椒药 对改善小鼠溃疡性结肠炎作用[J]. 生物医学, 2026, 16(4): 721-734. https://doi.org/10.12677/hjbm.2026.164074

参考文献

[1] Long, D. (2024) Crohn’s Disease and Ulcerative Colitis: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines, 12, Article 689. [Google Scholar] [CrossRef] [PubMed]
[2] Lin, W., Chang, C., Chen, M., Hsu, T. and Wang, H. (2019) Effectiveness of Sigmoidoscopy for Assessing Ulcerative Colitis Disease Activity and Therapeutic Response. Medicine, 98, e15748. [Google Scholar] [CrossRef] [PubMed]
[3] Gorospe, J., Windsor, J., Hracs, L., et al. (2024) Trends in Inflammatory Bowel Disease Incidence and Prevalence across Epidemiologic Stages: A Global Systematic Review with Meta-Analysis. Inflammatory Bowel Diseases, 30, 56-57.
[4] Lindsay, J.O., Picker, N., Kromer, D., Smyth, M. and Patel, H. (2023) The Incidence of Remission and Indicators of Inadequate Response to Advanced Therapy in Patients with Ulcerative Colitis: Results from Medical Charts in the United Kingdom. Current Medical Research and Opinion, 39, 681-689. [Google Scholar] [CrossRef] [PubMed]
[5] 李军祥, 唐旭东, 王化虹, 等. 溃疡性结肠炎中医诊疗指南(2023) [J]. 中医杂志, 2024, 65(7): 763-768.
[6] 何文玉. 中医治疗溃疡性结肠炎的进展[J]. 云南中医中药杂志, 2011, 32(8): 81-84.
[7] 朱燕, 刘大铭, 刘全喜, 等. 溃疡性结肠炎中医诊疗思路[J]. 医学信息, 2021, 34(3): 167-169.
[8] 刘晓兰, 张永忠, 张俊玲, 等. 苍术挥发油对溃疡性结肠炎大鼠的改善作用[J]. 天津医药, 2020, 48(10): 956-960.
[9] 吕景山. 施今墨对药[M]. 北京: 人民卫生出版社, 2019.
[10] 国家药典委员会. 中华人民共和国药典[M]. 北京: 中国医药科技出版社, 2025.
[11] Wu, M., An, Y., Li, Y., He, W., Wang, Y., Wang, Y., et al. (2026) Naringin Ameliorates Intestinal Injury in Ulcerative Colitis Model Mice by Modulating the JAK2/STAT3 Signaling Pathway. Molecular Medicine Reports, 33, 1-12. [Google Scholar] [CrossRef
[12] Wang, J., Zhang, C., Guo, C. and Li, X. (2019) Chitosan Ameliorates DSS-Induced Ulcerative Colitis Mice by Enhancing Intestinal Barrier Function and Improving Microflora. International Journal of Molecular Sciences, 20, Article 5751. [Google Scholar] [CrossRef] [PubMed]
[13] Shen, Y., Zou, J., Chen, M., Zhang, Z., Liu, C., Jiang, S., et al. (2020) Protective Effects of Lizhong Decoction on Ulcerative Colitis in Mice by Suppressing Inflammation and Ameliorating Gut Barrier. Journal of Ethnopharmacology, 259, Article ID: 112919. [Google Scholar] [CrossRef] [PubMed]
[14] Sun, M., Zhang, F., Yin, X., Cheng, B., Zhao, C., Wang, Y., et al. (2018) Lactobacillus reuteri F‐9‐35 Prevents DSS‐induced Colitis by Inhibiting Proinflammatory Gene Expression and Restoring the Gut Microbiota in Mice. Journal of Food Science, 83, 2645-2652. [Google Scholar] [CrossRef] [PubMed]
[15] Vacca, M., Celano, G., Calabrese, F.M., Portincasa, P., Gobbetti, M. and De Angelis, M. (2020) The Controversial Role of Human Gut Lachnospiraceae. Microorganisms, 8, Article 573. [Google Scholar] [CrossRef] [PubMed]